High materiality9/10
Astrana Health price target raised to $53 from $50 at Barclays
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises ASTH target to $53; current price $34.13. Upside potential remains.
- Target: $53 | Current: $34.13 | Upside ~55%
Key facts
- 01
Target: $53
- 02
Posted price: $34.13
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.